ADAMTS13 and antiphospholipid syndrome: Additionally, an imbalance of ADAMTS-13 activity and vWF plasma concentration are risk factors for the development of myocardial infarction, ischemic stroke, pre-eclampsia, malignant (or cerebral) malaria and antiphospholipid syndrome [25].